Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: An Australian and New Zealand Gynaecological Oncology Group study
- P Harnett*
- , M Buck
- , P Beale
- , A Goldrick
- , S Allan
- , B Fitzharris
- , P De Souza
- , M Links
- , G Kalimi
- , T Davies
- , R. Stuart-Harris
*Corresponding author for this work
Research output: Contribution to journal › Article › Research › peer-review
19
Link opens in a new tab
Citations
(Scopus)